The mechanisms of mucosal injury in gastritis and PUD are thought to be mainly caused by H pylori infections, coupled an imbalance of aggressive factors, such as acid production or pepsin, and defensive factors, such as mucus production, bicarbonate, and blood flow.
Erosive gastritis usually is associated with serious illness or with various drugs. Stress, ethanol, bile, and nonsteroidal anti-inflammatory drugs (NSAIDs) disrupt the gastric mucosal barrier, making it vulnerable to normal gastric secretions.
Infection with H pylori, a short, spiral-shaped, microaerophilic gram-negative bacillus, is the leading cause of PUD.H pylori colonize the deep layers of the mucosal gel that coats the gastric mucosa and presumably disrupts its protective properties.
NSAIDs and aspirin also interfere with the protective mucus layer by inhibiting mucosal cyclooxygenase activity, reducing levels of mucosal prostaglandins.such as dyspepsia or gastroesophageal reflux disease (GERD).
Gastrinoma (Zollinger-Ellison syndrome)
- Occurs 2-3 hours after meals.
-Relieved by food or antacids
-The pain sometimes extends to the back.
- Dyspepsia, including belching, bloating, distention, and fatty food intolerance
- Heartburn
- Loss of appetite and weight loss.
- Bloating or nausea after eating.
Pain from a duodenal ulcer may occur several hours after eating (when the stomach is empty) and may improve after eating. Pain also may wake you frequently in the middle of the night.
Pain from a gastric ulcer may occur shortly after eating (when food is still in the stomach).
Silent ulcers are more common in older adults, people who have diabetes, or people who use nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen (Advil), or naproxen (Aleve).
Bleeding
Perforation, penetration, or obstruction of the digestive tract.
Complications can happen in both silent ulcers and ulcers that cause symptoms.
Special tests:
These agents selectively block H2-receptors on parietal cells, resulting in diminished acid secretion and ulcer healing.
Long-term use can have tachyphalaxis.
Proton pump inhibitors bind to and inhibit the H+/K+ -adenosine triphosphatase (ATPase) pump of the parietal cell,
resulting in a marked decrease in acid secretion.These drugs are an important part of triple therapy, the treatment of choice
for H pylori infection.Can be used as primary therapy to heal ulcers not associated with H pylori infection.
Most patients with PUD are treated successfully with cure of H pylori infection and/or avoidance of NSAIDs,
along with the appropriate use of antisecretory therapy.
PPI-based triple therapies for H pylori are considered the first-line therapies for the treatment of H pylori.
These regimens consist of a PPI, amoxicillin, and clarithromycin for 7-14 days.
These agents have the ability to induce prostaglandin synthesis and, thus, cytoprotective effects in the GI tract.
Indications for surgical treatment are:
Highly selective vagotomy
Anterior seromyotomy and posterior truncal vagotomy